nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Sinus congestion—Metformin—polycystic ovary syndrome	0.0563	0.0569	CcSEcCtD
Valganciclovir—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0346	0.0349	CcSEcCtD
Valganciclovir—Rigors—Metformin—polycystic ovary syndrome	0.0343	0.0347	CcSEcCtD
Valganciclovir—Blood disorder—Metformin—polycystic ovary syndrome	0.0335	0.0339	CcSEcCtD
Valganciclovir—Ear pain—Metformin—polycystic ovary syndrome	0.0238	0.0241	CcSEcCtD
Valganciclovir—Nasal congestion—Metformin—polycystic ovary syndrome	0.0223	0.0226	CcSEcCtD
Valganciclovir—Renal impairment—Metformin—polycystic ovary syndrome	0.0214	0.0216	CcSEcCtD
Valganciclovir—Pain in extremity—Metformin—polycystic ovary syndrome	0.0203	0.0205	CcSEcCtD
Valganciclovir—Migraine—Metformin—polycystic ovary syndrome	0.02	0.0202	CcSEcCtD
Valganciclovir—Dehydration—Metformin—polycystic ovary syndrome	0.0189	0.0191	CcSEcCtD
Valganciclovir—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0186	0.0188	CcSEcCtD
Valganciclovir—Cramp muscle—Metformin—polycystic ovary syndrome	0.0183	0.0185	CcSEcCtD
Valganciclovir—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0182	0.0184	CcSEcCtD
Valganciclovir—Abdominal distension—Metformin—polycystic ovary syndrome	0.0177	0.0179	CcSEcCtD
Valganciclovir—Influenza—Metformin—polycystic ovary syndrome	0.0176	0.0178	CcSEcCtD
Valganciclovir—Pancreatitis—Metformin—polycystic ovary syndrome	0.0172	0.0174	CcSEcCtD
Valganciclovir—Sweating increased—Metformin—polycystic ovary syndrome	0.0171	0.0173	CcSEcCtD
Valganciclovir—Neutropenia—Metformin—polycystic ovary syndrome	0.0164	0.0166	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0163	0.0165	CcSEcCtD
Valganciclovir—Infestation—Metformin—polycystic ovary syndrome	0.0157	0.0158	CcSEcCtD
Valganciclovir—Infestation NOS—Metformin—polycystic ovary syndrome	0.0157	0.0158	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0154	0.0155	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.0148	0.015	CcSEcCtD
Valganciclovir—Hepatitis—Metformin—polycystic ovary syndrome	0.0141	0.0142	CcSEcCtD
Valganciclovir—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0139	0.014	CcSEcCtD
Valganciclovir—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0138	0.014	CcSEcCtD
Valganciclovir—Eye disorder—Metformin—polycystic ovary syndrome	0.0131	0.0133	CcSEcCtD
Valganciclovir—Cardiac disorder—Metformin—polycystic ovary syndrome	0.013	0.0132	CcSEcCtD
Valganciclovir—Angiopathy—Metformin—polycystic ovary syndrome	0.0128	0.0129	CcSEcCtD
Valganciclovir—Immune system disorder—Metformin—polycystic ovary syndrome	0.0127	0.0128	CcSEcCtD
Valganciclovir—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0127	0.0128	CcSEcCtD
Valganciclovir—Chills—Metformin—polycystic ovary syndrome	0.0126	0.0128	CcSEcCtD
Valganciclovir—Malnutrition—Metformin—polycystic ovary syndrome	0.0122	0.0124	CcSEcCtD
Valganciclovir—Flatulence—Metformin—polycystic ovary syndrome	0.0121	0.0122	CcSEcCtD
Valganciclovir—Dysgeusia—Metformin—polycystic ovary syndrome	0.012	0.0121	CcSEcCtD
Valganciclovir—Muscle spasms—Metformin—polycystic ovary syndrome	0.0118	0.0119	CcSEcCtD
Valganciclovir—Vision blurred—Metformin—polycystic ovary syndrome	0.0115	0.0117	CcSEcCtD
Valganciclovir—Tremor—Metformin—polycystic ovary syndrome	0.0115	0.0116	CcSEcCtD
Valganciclovir—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0114	0.0115	CcSEcCtD
Valganciclovir—Malaise—Metformin—polycystic ovary syndrome	0.011	0.0112	CcSEcCtD
Valganciclovir—Hypertension—Metformin—polycystic ovary syndrome	0.0106	0.0107	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0103	0.0105	CcSEcCtD
Valganciclovir—Discomfort—Metformin—polycystic ovary syndrome	0.0103	0.0104	CcSEcCtD
Valganciclovir—Oedema—Metformin—polycystic ovary syndrome	0.00999	0.0101	CcSEcCtD
Valganciclovir—Infection—Metformin—polycystic ovary syndrome	0.00992	0.01	CcSEcCtD
Valganciclovir—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0098	0.0099	CcSEcCtD
Valganciclovir—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00978	0.00989	CcSEcCtD
Valganciclovir—Skin disorder—Metformin—polycystic ovary syndrome	0.0097	0.00981	CcSEcCtD
Valganciclovir—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00966	0.00976	CcSEcCtD
Valganciclovir—Anorexia—Metformin—polycystic ovary syndrome	0.00952	0.00963	CcSEcCtD
Valganciclovir—Hypotension—Metformin—polycystic ovary syndrome	0.00933	0.00944	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0091	0.0092	CcSEcCtD
Valganciclovir—Paraesthesia—Metformin—polycystic ovary syndrome	0.00897	0.00907	CcSEcCtD
Valganciclovir—Dyspnoea—Metformin—polycystic ovary syndrome	0.00891	0.009	CcSEcCtD
Valganciclovir—Somnolence—Metformin—polycystic ovary syndrome	0.00888	0.00898	CcSEcCtD
Valganciclovir—Dyspepsia—Metformin—polycystic ovary syndrome	0.00879	0.00889	CcSEcCtD
Valganciclovir—Decreased appetite—Metformin—polycystic ovary syndrome	0.00868	0.00878	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00862	0.00872	CcSEcCtD
Valganciclovir—Fatigue—Metformin—polycystic ovary syndrome	0.00861	0.00871	CcSEcCtD
Valganciclovir—Constipation—Metformin—polycystic ovary syndrome	0.00854	0.00864	CcSEcCtD
Valganciclovir—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00823	0.00832	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00817	0.00826	CcSEcCtD
Valganciclovir—Urticaria—Metformin—polycystic ovary syndrome	0.00794	0.00802	CcSEcCtD
Valganciclovir—Abdominal pain—Metformin—polycystic ovary syndrome	0.0079	0.00798	CcSEcCtD
Valganciclovir—Asthenia—Metformin—polycystic ovary syndrome	0.00717	0.00725	CcSEcCtD
Valganciclovir—Pruritus—Metformin—polycystic ovary syndrome	0.00707	0.00715	CcSEcCtD
Valganciclovir—Diarrhoea—Metformin—polycystic ovary syndrome	0.00683	0.00691	CcSEcCtD
Valganciclovir—Dizziness—Metformin—polycystic ovary syndrome	0.00661	0.00668	CcSEcCtD
Valganciclovir—Vomiting—Metformin—polycystic ovary syndrome	0.00635	0.00642	CcSEcCtD
Valganciclovir—Dermatitis—Metformin—polycystic ovary syndrome	0.00629	0.00636	CcSEcCtD
Valganciclovir—Headache—Metformin—polycystic ovary syndrome	0.00626	0.00633	CcSEcCtD
Valganciclovir—Nausea—Metformin—polycystic ovary syndrome	0.00593	0.006	CcSEcCtD
Valganciclovir—SLC6A14—endocrine gland—polycystic ovary syndrome	0.00365	0.335	CbGeAlD
Valganciclovir—SLC15A1—endometrium—polycystic ovary syndrome	0.00131	0.12	CbGeAlD
Valganciclovir—SLC15A1—vagina—polycystic ovary syndrome	0.000984	0.0902	CbGeAlD
Valganciclovir—SLC15A1—endocrine gland—polycystic ovary syndrome	0.00092	0.0844	CbGeAlD
Valganciclovir—SLC15A2—endometrium—polycystic ovary syndrome	0.000821	0.0753	CbGeAlD
Valganciclovir—SLC15A2—pituitary gland—polycystic ovary syndrome	0.000743	0.0681	CbGeAlD
Valganciclovir—SLC15A2—adrenal gland—polycystic ovary syndrome	0.000663	0.0609	CbGeAlD
Valganciclovir—SLC15A2—female gonad—polycystic ovary syndrome	0.000619	0.0567	CbGeAlD
Valganciclovir—SLC15A2—vagina—polycystic ovary syndrome	0.000615	0.0564	CbGeAlD
Valganciclovir—SLC15A2—endocrine gland—polycystic ovary syndrome	0.000575	0.0528	CbGeAlD
